Metis Global Partners, LLC Royalty Pharma PLC Transaction History
Metis Global Partners, LLC
- $3.79 Billion
- Q2 2025
A detailed history of Metis Global Partners, LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Metis Global Partners, LLC holds 67,880 shares of RPRX stock, worth $2.51 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
67,880
Previous 36,921
83.85%
Holding current value
$2.51 Million
Previous $1.15 Million
112.79%
% of portfolio
0.06%
Previous 0.03%
Shares
7 transactions
Others Institutions Holding RPRX
# of Institutions
501Shares Held
287MCall Options Held
2.51MPut Options Held
940K-
Morgan Stanley New York, NY41MShares$1.52 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.7MShares$1.36 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$852 Million0.01% of portfolio
-
Baillie Gifford & CO18MShares$667 Million0.51% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$450 Million0.51% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $16.2B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...